The effects of pretreatment with androgen blocking hormones before brachytherapy for prostate cancer on the course of PSA and testosterone after treatment
- Registry ID
- EUCTR2011-004749-41
- Source registry
- EUCTR
- Status
- Ongoing
- Phase
- PHASE4
- Sponsor
- TweeSteden hospital
- Start date
- 2011-12-13
- Last update
- 2026-08-16
Conditions
- Localized prostate cancer
Summary
Assess the effects of 3-month NHT with Eligard 22.5 mg once and Bicalutamide 50 mg daily on the course of PSA in patients treated with BT for low-intermediate risk localized prostate carcinoma
Locations
View on source registry